Atala Financial’s Avanos Medical AVNS Stock Holding History

Atala Financial’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7	Closed	-$100	–	158
2025 Q1	$100	Hold	7	–	–	﹤0.01%	469
2024 Q4	$111	Buy	+7	New	+$139	﹤0.01%	473

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Atala Financial's AVNS Position: Q2 2025 in Review

Atala Financial sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 7 shares — an estimated $100 sold.

Atala Financial first reported a position in AVNS in Q4 2024 and held it in 2 quarters. The position peaked at $111 in Q4 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

Atala Financial reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
Atala Financial sold 7 Avanos Medical shares in Q2 2025, an estimated $100.
Atala Financial first reported a position in Avanos Medical in Q4 2024 and held it in 2 quarters.
Atala Financial's Avanos Medical position peaked at $111 in Q4 2024.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Atala Financial's 13F filing for Q2 2025, filed 7 Aug 2025.